======= PIH1D1 ======= == Gene Information == * **Official Symbol**: PIH1D1 * **Official Name**: PIH1 domain containing 1 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=55011|55011]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q9NWS0|Q9NWS0]] * **Interactions**: [[https://thebiogrid.org/search.php?search=PIH1D1&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20PIH1D1|Open PubMed]] * **OMIM**: [[https://omim.org/entry/611480|Open OMIM]] == Function Summary == * **Entrez Summary**: N/A * **UniProt Summary**: Involved in the assembly of C/D box small nucleolar ribonucleoprotein (snoRNP) particles (PubMed:17636026). Recruits the SWI/SNF complex to the core promoter of rRNA genes and enhances pre-rRNA transcription (PubMed:22368283, PubMed:24036451). Mediates interaction of TELO2 with the R2TP complex which is necessary for the stability of MTOR and SMG1 (PubMed:20864032). Positively regulates the assembly and activity of the mTORC1 complex (PubMed:24036451). {ECO:0000269|PubMed:17636026, ECO:0000269|PubMed:20864032, ECO:0000269|PubMed:22368283, ECO:0000269|PubMed:24036451}. |PIH1| |RNA polymerase I upstream control element sequence-specific DNA binding| |negative regulation of histone H3-K9 dimethylation| |positive regulation of glucose mediated signaling pathway| |regulation of TORC2 signaling| |negative regulation of histone H4-K16 acetylation| |regulation of histone H3-K9 dimethylation| |regulation of glucose mediated signaling pathway| |R2TP complex| |negative regulation of histone H3-K9 trimethylation| |negative regulation of histone H4 acetylation| |snoRNA localization| |negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway| |regulation of histone H4-K16 acetylation| |pre-snoRNP complex| |positive regulation of histone H4 acetylation| |establishment of protein localization to chromatin| |positive regulation of histone H3-K9 acetylation| |RNA polymerase I CORE element sequence-specific DNA binding| |RNA polymerase I preinitiation complex assembly| |box C/D snoRNP assembly| |positive regulation of transcription of nucleolar large rRNA by RNA polymerase I| |small nucleolar ribonucleoprotein complex assembly| |regulation of histone H3-K9 trimethylation| |negative regulation of histone H3-K9 methylation| |regulation of histone H4 acetylation| |regulation of transcription of nucleolar large rRNA by RNA polymerase I| |regulation of histone H3-K9 acetylation| |negative regulation of histone acetylation| |establishment of protein localization to chromosome| |positive regulation of TORC1 signaling| |regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway| |negative regulation of peptidyl-lysine acetylation| |negative regulation of histone methylation| |negative regulation of protein acetylation| |positive regulation of transcription by RNA polymerase I| |regulation of histone H3-K9 methylation| |protein localization to chromatin| |regulation of histone H3-K4 methylation| |transcription preinitiation complex assembly| |positive regulation of histone acetylation| |regulation of transcription by RNA polymerase I| |positive regulation of peptidyl-lysine acetylation| |phosphoprotein binding| |transcription initiation from RNA polymerase I promoter| |positive regulation of TOR signaling| |transcription by RNA polymerase I| |regulation of TORC1 signaling| |positive regulation of protein acetylation| |negative regulation of histone modification| |regulation of histone acetylation| |negative regulation of chromatin organization| |regulation of peptidyl-lysine acetylation| |protein localization to chromosome| |regulation of histone methylation| |regulation of protein acetylation| |ATPase binding| |negative regulation of cysteine-type endopeptidase activity involved in apoptotic process| |negative regulation of cysteine-type endopeptidase activity| |positive regulation of histone modification| |regulation of TOR signaling| |positive regulation of chromatin organization| |histone binding| |negative regulation of chromosome organization| |regulation of histone modification| |chromatin remodeling| |positive regulation of chromosome organization| |regulation of chromatin organization| |protein-DNA complex assembly| |rRNA processing| |regulation of cysteine-type endopeptidase activity involved in apoptotic process| |DNA-templated transcription, initiation| |RNA localization| |rRNA metabolic process| |negative regulation of apoptotic signaling pathway| |ribonucleoprotein complex assembly| |regulation of cysteine-type endopeptidase activity| |protein-DNA complex subunit organization| |negative regulation of endopeptidase activity| |ribonucleoprotein complex subunit organization| |positive regulation of protein complex assembly| |negative regulation of peptidase activity| |ribosome biogenesis| |positive regulation of protein serine/threonine kinase activity| |regulation of chromosome organization| |negative regulation of proteolysis| |negative regulation of organelle organization| |ncRNA processing| |regulation of apoptotic signaling pathway| |regulation of endopeptidase activity| |establishment of protein localization to organelle| |regulation of peptidase activity| |regulation of protein complex assembly| |negative regulation of hydrolase activity| |ribonucleoprotein complex biogenesis| |protein kinase binding| |ncRNA metabolic process| |regulation of protein serine/threonine kinase activity| |positive regulation of cellular component biogenesis| |positive regulation of protein kinase activity| |positive regulation of kinase activity| |negative regulation of protein modification process| |positive regulation of organelle organization| |transcription, DNA-templated| |nucleic acid-templated transcription| |RNA biosynthetic process| |positive regulation of transferase activity| |epithelial cell differentiation| |chromatin organization| |negative regulation of cellular component organization| |regulation of proteolysis| |protein localization to organelle| |negative regulation of catalytic activity| |regulation of protein kinase activity| |cellular protein-containing complex assembly| |nucleolus| |regulation of kinase activity| |RNA processing| |negative regulation of apoptotic process| |negative regulation of programmed cell death| |regulation of cellular component biogenesis| |regulation of transferase activity| |negative regulation of cell death| |positive regulation of protein phosphorylation| |positive regulation of intracellular signal transduction| |negative regulation of cellular protein metabolic process| |positive regulation of phosphorylation| |chromosome organization| |nucleobase-containing compound biosynthetic process| |negative regulation of protein metabolic process| |epithelium development| |positive regulation of phosphorus metabolic process| |positive regulation of phosphate metabolic process| |negative regulation of molecular function| |heterocycle biosynthetic process| |aromatic compound biosynthetic process| |positive regulation of cellular component organization| |positive regulation of protein modification process| |negative regulation of signal transduction| |regulation of hydrolase activity| |regulation of organelle organization| |organic cyclic compound biosynthetic process| |negative regulation of cell communication| |negative regulation of signaling| |positive regulation of catalytic activity| |regulation of protein phosphorylation| |positive regulation of transcription, DNA-templated| |regulation of apoptotic process| |protein-containing complex assembly| |regulation of programmed cell death| |cellular protein localization| |regulation of phosphorylation| |cellular macromolecule localization| |positive regulation of cellular protein metabolic process| |establishment of protein localization| |negative regulation of response to stimulus| |cellular nitrogen compound biosynthetic process| |positive regulation of nucleic acid-templated transcription| |positive regulation of RNA biosynthetic process| |positive regulation of signal transduction| |RNA metabolic process| |regulation of cell death| |positive regulation of protein metabolic process| |cellular macromolecule biosynthetic process| |positive regulation of RNA metabolic process| |tissue development| |macromolecule biosynthetic process| |positive regulation of molecular function| |regulation of phosphate metabolic process| |regulation of phosphorus metabolic process| |positive regulation of cell communication| |positive regulation of signaling| |regulation of intracellular signal transduction| |regulation of protein modification process| |protein-containing complex subunit organization| |positive regulation of nucleobase-containing compound metabolic process| |positive regulation of macromolecule biosynthetic process| |positive regulation of cellular biosynthetic process| |positive regulation of gene expression| |gene expression| |positive regulation of biosynthetic process| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp447|Amiloride 100μM R08 exp447]]|1.7| |[[:results:exp66|BI-D1870 3.15μM R02 exp66]]|1.71| |[[:results:exp307|Rapamycin 2μM plus Cyclosporin-A 3μM R07 exp307]]|1.79| |[[:results:exp306|Rapamycin 2μM R07 exp306]]|1.79| |[[:results:exp492|iCRT14 30μM R08 exp492]]|1.82| |[[:results:exp500|LY2090314 0.003μM R08 exp500 no dilution day6]]|1.83| |[[:results:exp502|Milciclib 2μM R08 exp502]]|1.89| |[[:results:exp120|Dimethyl-Sulfoxide 1pc R03 exp120]]|1.93| |[[:results:exp317|Geldanamycin 0.015 to 0.05μM on day4 R07 exp317]]|2.11| |[[:results:exp439|QNZ 0.01μM R08 exp439]]|2.11| |[[:results:exp102|Nifuroxazide 5μM R03 exp102]]|2.31| |[[:results:exp497|Lead acetate 2000μM R08 exp497]]|2.35| |[[:results:exp282|Fluvastatin 2.2μM R06 exp282]]|2.75| |[[:results:exp365|I-BRD9 4μM R07 exp365]]|2.8| |[[:results:exp498|Lead acetate 2000μM R08 exp498 no dilution day6]]|2.83| |[[:results:exp84|UM0125461 0.74μM R02 exp84]]|2.84| |[[:results:exp416|Tubacin 1.6μM R07 exp416]]|3.32| |[[:results:exp226|Cerivastatin 0.15μM R05 exp226]]|3.51| ^Gene^Correlation^ |[[:human genes:n:nfrkb|NFRKB]]|0.538| |[[:human genes:u:uchl5|UCHL5]]|0.46| |[[:human genes:r:rrm1|RRM1]]|0.456| |[[:human genes:i:ino80c|INO80C]]|0.439| |[[:human genes:a:actr5|ACTR5]]|0.429| |[[:human genes:t:tfpt|TFPT]]|0.426| |[[:human genes:z:zbtb17|ZBTB17]]|0.414| Global Fraction of Cell Lines Where Essential: 0/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/26| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 4422 * **Expression level (log2 read counts)**: 6.05 {{:chemogenomics:nalm6 dist.png?nolink |}}